Company performance
Add to research
Current Price
as of Apr 25, 2025$76.04
P/E Ratio
30.71
Market Cap
$44.54B
Loading...
Description
Add to research
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Metrics
Add to research
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEW
- Price$76.04+1.21%
Trading Information
- Market cap$44.54B
- Float98.05%
- Average Daily Volume (1m)5,425,116
- Average Daily Volume (3m)4,762,142
- EPS$2.48
Company
- Revenue$5.54B
- Rev growth (1yr)-11.61%
- Net income$365.20M
- Gross margin78.75%
- EBITDA marginN/A
- EBITDAN/A
- EV$40.10B
- EV/Revenue7.24
- P/E30.71
- P/S8.07
- P/B4.48
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
StreetAccount Metrics Recap - Edwards Lifesciences Q3 Earnings ($68.34, 0.00) (2023-10-25T20:22:05Z)
Factset